Skip to content

Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy

Tissue Oximetry's Measurement in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy: Prospective Observational Study With Device

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06475261
Enrollment
50
Registered
2024-06-26
Start date
2024-07-27
Completion date
2025-09-30
Last updated
2025-03-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury, Ovarian Carcinoma, Oxygen Deficiency

Keywords

Tissue Oximetry, Hyperthermic Intraperitoneal Chemotherapy, Acute Kidney Injury, Hemodynamics parameters

Brief summary

Tissue oximetry obtained from peripheral muscle measures the state of tissue oxygenation of various organs and, as already widely described in the literature, can be used to measure the state of kidney's tissue oxygenation. However, there is no evidence in the existing scientific literature on the use of muscle tissue oximetry in patients undergoing cytoreductive surgery for ovarian cancer with hyperthermic intraperitoneal chemotherapy. The primary objective of our study is to evaluate whether there is a correlation between average intraoperative muscle tissue oximetry below 65% (a value which is considered critical in the literature for the resulting cellular damage) and postoperative renal damage in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for ovarian cancer.

Detailed description

Tissue oximetry obtained from peripheral muscle can be used to measure the state of kidney's tissue oxygenation. 50 Adult female patients ASA 1-2 undergoing cytoreductive surgery with laparoscopic or laparotomy technique (for ovarian cancer) associated with hyperthermic intraperitoneal chemotherapy will be enrolled. The primary objective of our study is to evaluate whether there is a correlation between average intraoperative muscle tissue oximetry below 65% (a value which is considered critical in the literature for the resulting cellular damage) and postoperative renal damage (according to the AKIN and KIDGO classification) in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for ovarian cancer. Secondary objectives are: * describe the variation in muscle tissue oximetry and hemodynamic parameters (systolic, mean, diastolic blood pressure) during cytoreductive surgery with hyperthermic intraperitoneal chemotherapy . * describe the variation in renal function values (blood urea nitrogen, creatinine) and serum electrolytes (sodium, potassium, chloremia, calcemia) in the post-operative period (from the first to the seventh postoperative day).

Interventions

DEVICETissue Oximetry with ForeSight

Evaluation of a correlation between average intraoperative muscle tissue oximetry and postoperative renal damage in patients undergoing cytoreductive surgery with HIPEC for ovarian cancer

Sponsors

Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* American Society Anesthesiologists (ASA) Classification 1-2 * Cytoreductive surgery for ovarian cancer with laparoscopic or laparotomic technique with Hypertermic Intraperitoneal Chemotherapy.

Exclusion criteria

* Age \< 18 years * ASA \> or = 3 * Cytoreductive surgery without hyperthermic intraperitoneal chemotherapy

Design outcomes

Primary

MeasureTime frameDescription
Correlation between intraoperative tissue oximetry and postoperative acute renal injury.Tissue oximetry is defined as TWA (time-weighted average) value resulted by values recorded intraoperatively every 20 minutes.An intraoperative mean tissue oximetry value of 65% or less is considered to predict cellular damage. Postoperative renal injury is classified according to AKIN and KIDGO criteria.

Secondary

MeasureTime frameDescription
Tissue oximetry during hyperthermic intraperitoneal chemotherapyTWA value resulted by intraoperative values recorded every 20 minutes during hyperthermic intraperitoneal chemotherapy .Describing variation of tissue oximetry during hyperthermic intraperitoneal chemotherapy, expressed in percent.
Emodinamic parameters (systolic, mean and diastolic pressures)Intraoperatively, a mean value resulted by values recorded every 20 minutes during surgery.Describing mean values of intraoperative arterial pressure (systolic, mean and diastolic pressures), expressed in mmHg
Emodinamic parameters (systolic, mean and diastolic pressures) during hyperthermic intraperitoneal chemotherapyA mean value resulted by values recorded every 20 minutes during hyperthermic intraperitoneal chemotherapyDescribing mean values of arterial pressure (systolic, mean and diastolic pressures), expressed in mmHg, during hyperthermic intraperitoneal chemotherapy
Serum Creatinine levelFrom 1st to 7th postoperative daysMean value of creatinine, daily assessed for the first 7 postoperative days, expressed in mg/dL
Tissue oximetryTWA value resulted by intraoperative values recorded every 20 minutes during surgery.Describing intraoperative variation of tissue oximetry expressed in percent.
Serum sodium levelFrom 1st to 7th postoperative dayMean values of Serum sodium, daily assessed for the first 7 postoperative days, expressed in mmol/L
Serum Potassium levelFrom 1st to 7th postoperative dayMean values of Serum potassium, daily assessed for the first 7 postoperative days, expressed in mmol/L
Serum Chloride levelFrom 1st to 7th postoperative dayMean values of Serum chloride, daily assessed for the first 7 postoperative days, expressed in mmol/L
Serum Calcium levelFrom 1st to 7th postoperative dayMean values of Serum calcium, daily assessed for the first 7 postoperative days, expressed in mmol/L
Serum Blood urea nitrogen levelFrom 1st to 7th postoperative dayMean value of Serum blood urea nitrogen, daily assessed for the first 7 postoperative days, expressed in mg/dL

Countries

Italy

Contacts

Primary ContactStefano Catarci, MD
stefano.catarci@policlinicogemelli.it0630153744

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026